Financial reports
Current reports
6-K
Current report (foreign)
24 May 24
6-K
Apollomics Announces Private Placement Financing and Addition to Board of Directors
8 May 24
6-K
Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
25 Apr 24
6-K
Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
28 Mar 24
6-K
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
4 Mar 24
6-K
Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
19 Jan 24
6-K
Current report (foreign)
8 Jan 24
6-K
Index to Condensed Consolidated Interim Financial Statements
28 Sep 23
6-K
Current report (foreign)
20 Jul 23
6-K
Apollomics, a Company Developing Novel Oncology Therapies to
30 Mar 23
Registration and prospectus
424B3
Prospectus supplement
29 May 24
424B5
Prospectus supplement for primary offering
24 May 24
F-3
Shelf registration (foreign)
20 May 24
424B3
Prospectus supplement
24 Apr 24
424B3
Prospectus supplement
24 Apr 24
F-3/A
Shelf registration (foreign) (amended)
19 Apr 24
F-3/A
Shelf registration (foreign) (amended)
19 Apr 24
F-3
Shelf registration (foreign)
1 Apr 24
F-3
Shelf registration (foreign)
1 Apr 24
424B3
Prospectus supplement
4 Mar 24
Proxies
No filings
Other
EFFECT
Notice of effectiveness
30 May 24
EFFECT
Notice of effectiveness
25 Apr 24
EFFECT
Notice of effectiveness
25 Apr 24
EFFECT
Notice of effectiveness
2 Oct 23
EFFECT
Notice of effectiveness
25 Jul 23
CORRESP
Correspondence with SEC
20 Jul 23
CORRESP
Correspondence with SEC
7 Jul 23
UPLOAD
Letter from SEC
23 Jun 23
CERT
Certification of approval for exchange listing
29 Mar 23
SEC STAFF
SEC staff action: Order
6 Mar 23
Ownership
SC 13G/A
Maxpro Investment Co., Ltd
30 May 24
SC 13D/A
ORBIMED ADVISORS LLC
22 May 24
SC 13G
Maxpro Investment Co., Ltd
20 May 24
SC 13G
Chen Hung-Wen
20 May 24
SC 13G
Alpha Intelligence Enterprises Ltd.
27 Feb 24
SC 13D/A
ORBIMED ADVISORS LLC
29 Nov 23
144
Notice of proposed sale of securities
27 Nov 23
SC 13D/A
ORBIMED ADVISORS LLC
20 Nov 23
144
Notice of proposed sale of securities
16 Nov 23
SC 13D/A
ORBIMED ADVISORS LLC
1 Nov 23